Summary by Futu AI
Erqi Wang, a significant shareholder in Jin Medical International Ltd., has filed a Schedule 13G with the United States Securities and Exchange Commission (SEC) on December 31, 2023, indicating a substantial ownership stake in the company. According to the filing, Wang holds a total of 107,126,140 ordinary shares, representing 68.43% of the company's class of securities after adjustments for a 20-for-1 forward stock split effective February 8, 2024. This ownership includes direct holdings through Jolly Harmony Enterprises Limited and Er Pu International Limited, both entities organized under the laws of the British Virgin Islands. Jolly Harmony Enterprises Limited, wholly owned by Wang, holds 95,381,140 shares, amounting to 60.93% of the class, while Er Pu International Limited, in which Wang has a 67% ownership, holds 11,745,000 shares, representing 7.50% of the class. The filing, completed on February 14, 2024, asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Jin Medical International Ltd.